Computers in Human Behavior, ISSN 0747-5632, 02/2016, Volume 55, pp. 51 - 61
In an always connected communication environment, users of social networking services (SNSs) need to pay continuous attention to the overwhelming volume of...
SNS | Communication overload | Information overload | SNS fatigue | ICT overload | System feature overload | FACEBOOK | TURNOVER | PSYCHOLOGY, EXPERIMENTAL | PSYCHOLOGY, MULTIDISCIPLINARY | SATISFACTION | ORGANIZATIONS | CONSEQUENCES | WORK | ANTECEDENTS | JOB | USERS | TECHNOSTRESS | Stress (Psychology) | Social networks | Fatigue
SNS | Communication overload | Information overload | SNS fatigue | ICT overload | System feature overload | FACEBOOK | TURNOVER | PSYCHOLOGY, EXPERIMENTAL | PSYCHOLOGY, MULTIDISCIPLINARY | SATISFACTION | ORGANIZATIONS | CONSEQUENCES | WORK | ANTECEDENTS | JOB | USERS | TECHNOSTRESS | Stress (Psychology) | Social networks | Fatigue
Journal Article
Free Radical Biology and Medicine, ISSN 0891-5849, 11/2015, Volume 88, Issue Pt A, pp. 3 - 9
With repeated blood transfusions, patients with thalassemia major rapidly become loaded with iron, often surpassing hepatic metal accumulation capacity within...
Iron overload | Reactive oxygen species | Labile plasma iron | Transfusion | Iron chelation therapy | Free radicals | Thalassemia major | Iron cardiomyopathy | Labile cellular iron | OVERLOAD | BIOCHEMISTRY & MOLECULAR BIOLOGY | TOXICITY | RANDOMIZED CONTROLLED-TRIAL | MYOCARDIAL IRON | Iron cardionayopathy | TRANSFERRIN-BOUND IRON | LABILE IRON | DEFEROXAMINE | ENDOCRINOLOGY & METABOLISM | DEFERIPRONE | CALCIUM-CHANNEL | CHELATION | Iron Chelating Agents - therapeutic use | Transferrin | Iron Overload - drug therapy | Humans | Cardiomyopathies - prevention & control | Cardiomyopathies - etiology | Iron Overload - physiopathology | Iron Overload - etiology | Cardiomyopathies - physiopathology | Iron Overload - complications | Thalassemia - complications | Oxidative Stress - drug effects | Thalassemia - physiopathology | Oxidative stress | Enzymes | Calcium channels | Implants, Artificial | Prosthesis | Cardiac patients | Physiological aspects | Thalassemia | Mitochondrial DNA | Index Medicus
Iron overload | Reactive oxygen species | Labile plasma iron | Transfusion | Iron chelation therapy | Free radicals | Thalassemia major | Iron cardiomyopathy | Labile cellular iron | OVERLOAD | BIOCHEMISTRY & MOLECULAR BIOLOGY | TOXICITY | RANDOMIZED CONTROLLED-TRIAL | MYOCARDIAL IRON | Iron cardionayopathy | TRANSFERRIN-BOUND IRON | LABILE IRON | DEFEROXAMINE | ENDOCRINOLOGY & METABOLISM | DEFERIPRONE | CALCIUM-CHANNEL | CHELATION | Iron Chelating Agents - therapeutic use | Transferrin | Iron Overload - drug therapy | Humans | Cardiomyopathies - prevention & control | Cardiomyopathies - etiology | Iron Overload - physiopathology | Iron Overload - etiology | Cardiomyopathies - physiopathology | Iron Overload - complications | Thalassemia - complications | Oxidative Stress - drug effects | Thalassemia - physiopathology | Oxidative stress | Enzymes | Calcium channels | Implants, Artificial | Prosthesis | Cardiac patients | Physiological aspects | Thalassemia | Mitochondrial DNA | Index Medicus
Journal Article
3.
Full Text
The Impact of Mental Representations on ICT-Related Overload in the Use of Mobile Phones
Journal of Management Information Systems, ISSN 0742-1222, 07/2017, Volume 34, Issue 3, pp. 803 - 825
The use of information and communication technology (ICT) can be accompanied by the epiphenomenon of ICT-related overload, or the emotional and cognitive state...
communication overload | information overload | mental representations | ICT-related overload | cognitive overload | mobile phone use | emotional overload | feature overload | polychronicity | DECISION | MANAGEMENT | LOAD | MULTITASKING | COMPUTER SCIENCE, INFORMATION SYSTEMS | BEHAVIORAL-RESEARCH | INDIVIDUALS | ORGANIZATIONS | PLS | INFORMATION SCIENCE & LIBRARY SCIENCE | SEM | TECHNOSTRESS
communication overload | information overload | mental representations | ICT-related overload | cognitive overload | mobile phone use | emotional overload | feature overload | polychronicity | DECISION | MANAGEMENT | LOAD | MULTITASKING | COMPUTER SCIENCE, INFORMATION SYSTEMS | BEHAVIORAL-RESEARCH | INDIVIDUALS | ORGANIZATIONS | PLS | INFORMATION SCIENCE & LIBRARY SCIENCE | SEM | TECHNOSTRESS
Journal Article
Nature Genetics, ISSN 1061-4036, 04/2009, Volume 41, Issue 4, pp. 478 - 481
Expression of hepcidin, a key regulator of intestinal iron absorption, can be induced in vitro by several bone morphogenetic proteins (BMPs), including BMP2,...
TFR2 | FERROPORTIN | MEMBRANE | HFE | GENETICS & HEREDITY | HEPCIDIN | MICE | MODEL | EXPRESSION | HEMOJUVELIN | HEMOCHROMATOSIS | Liver - pathology | Iron Overload - genetics | Humans | RNA, Messenger - genetics | Gene Expression Regulation | Bone Morphogenetic Protein 6 - deficiency | Iron Overload - pathology | Iron - metabolism | Mice, Knockout | Animals | Bone Morphogenetic Protein 6 - genetics | Iron Overload - metabolism | Spleen - metabolism | Mice | Messenger RNA | Physiological aspects | Bone morphogenetic proteins | Iron metabolism disorders | Genetic aspects | Cellular signal transduction | Research | Health aspects | Risk factors | Proteins | Mathematical models | Infrared imaging systems | Kinases | Rodents | Cells | Spleen | Bone Morphogenetic Protein 6 | Liver | Iron | Cellular Biology | Life Sciences | RNA, Messenger | Iron Overload
TFR2 | FERROPORTIN | MEMBRANE | HFE | GENETICS & HEREDITY | HEPCIDIN | MICE | MODEL | EXPRESSION | HEMOJUVELIN | HEMOCHROMATOSIS | Liver - pathology | Iron Overload - genetics | Humans | RNA, Messenger - genetics | Gene Expression Regulation | Bone Morphogenetic Protein 6 - deficiency | Iron Overload - pathology | Iron - metabolism | Mice, Knockout | Animals | Bone Morphogenetic Protein 6 - genetics | Iron Overload - metabolism | Spleen - metabolism | Mice | Messenger RNA | Physiological aspects | Bone morphogenetic proteins | Iron metabolism disorders | Genetic aspects | Cellular signal transduction | Research | Health aspects | Risk factors | Proteins | Mathematical models | Infrared imaging systems | Kinases | Rodents | Cells | Spleen | Bone Morphogenetic Protein 6 | Liver | Iron | Cellular Biology | Life Sciences | RNA, Messenger | Iron Overload
Journal Article
Haematologica, ISSN 0390-6078, 11/2011, Volume 96, Issue 11, pp. 1605 - 1612
Background Patients with beta thalassemia intermedia can have substantial iron overload, irrespectively of their transfusion status, secondary to increased...
Iron overload | Vascular disease | Osteoporosis | Thalassemia intermedia | Liver iron concentration | Endocrine disease | OVERLOAD | iron overload | endocrine disease | PULMONARY ARTERIAL-HYPERTENSION | INEFFECTIVE ERYTHROPOIESIS | osteoporosis | thalassemia intermedia | SERUM FERRITIN | HYPERCOAGULABLE STATE | HEART-DISEASE | liver iron concentration | vascular disease | CHELATING THERAPY | SPLENECTOMIZED PATIENTS | MAGNETIC-RESONANCE | SICKLE-CELL-DISEASE | HEMATOLOGY | Blood Platelets - pathology | beta-Thalassemia - pathology | Liver - pathology | Iron Overload - mortality | Humans | Middle Aged | Male | Erythrocytes, Abnormal - metabolism | Iron Overload - pathology | beta-Thalassemia - mortality | Splenectomy | Blood Transfusion | Ferritins - blood | Iron Overload - metabolism | Adult | Female | Fetal Hemoglobin - metabolism | Biomarkers - metabolism | Cross-Sectional Studies | Liver - metabolism | Iron - metabolism | Erythrocytes, Abnormal - pathology | Platelet Count | Blood Platelets - metabolism | beta-Thalassemia - metabolism | Erythrocyte Count | Original Research
Iron overload | Vascular disease | Osteoporosis | Thalassemia intermedia | Liver iron concentration | Endocrine disease | OVERLOAD | iron overload | endocrine disease | PULMONARY ARTERIAL-HYPERTENSION | INEFFECTIVE ERYTHROPOIESIS | osteoporosis | thalassemia intermedia | SERUM FERRITIN | HYPERCOAGULABLE STATE | HEART-DISEASE | liver iron concentration | vascular disease | CHELATING THERAPY | SPLENECTOMIZED PATIENTS | MAGNETIC-RESONANCE | SICKLE-CELL-DISEASE | HEMATOLOGY | Blood Platelets - pathology | beta-Thalassemia - pathology | Liver - pathology | Iron Overload - mortality | Humans | Middle Aged | Male | Erythrocytes, Abnormal - metabolism | Iron Overload - pathology | beta-Thalassemia - mortality | Splenectomy | Blood Transfusion | Ferritins - blood | Iron Overload - metabolism | Adult | Female | Fetal Hemoglobin - metabolism | Biomarkers - metabolism | Cross-Sectional Studies | Liver - metabolism | Iron - metabolism | Erythrocytes, Abnormal - pathology | Platelet Count | Blood Platelets - metabolism | beta-Thalassemia - metabolism | Erythrocyte Count | Original Research
Journal Article
Nature Genetics, ISSN 1061-4036, 2014, Volume 46, Issue 7, pp. 678 - 684
Recovery from blood loss requires a greatly enhanced supply of iron to support expanded erythropoiesis. After hemorrhage, suppression of the iron-regulatory...
OVERLOAD | HOMEOSTASIS | DIFFERENTIATION FACTOR 15 | BETA-THALASSEMIA-INTERMEDIA | ERYTHROPOIESIS | GENETICS & HEREDITY | MOUSE-LIVER | MICE | HEPCIDIN EXPRESSION | ANEMIA | HYPOXIA | Hepcidins - metabolism | beta-Thalassemia - pathology | Liver - pathology | Iron Overload - drug therapy | Molecular Sequence Data | Erythropoiesis - drug effects | Male | Gene Expression Profiling | Iron Overload - pathology | Iron Overload - metabolism | Epoetin Alfa | Erythropoietin - metabolism | Real-Time Polymerase Chain Reaction | Anemia - etiology | Disease Models, Animal | Recombinant Proteins - metabolism | Hormones - pharmacology | Enzyme-Linked Immunosorbent Assay | Liver - metabolism | Mice, Inbred C57BL | RNA, Messenger - genetics | Hemorrhage - complications | Hemoglobins - metabolism | Hemorrhage - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Iron - metabolism | Blotting, Western | Erythropoiesis - physiology | Mice, Knockout | Anemia - metabolism | Animals | Mice | beta-Thalassemia - metabolism | Physiological aspects | Genetic research | Genetic aspects | Iron in the body | Hormones | Research | Genetic regulation | Identification and classification | Flow cytometry | Plasma | Phosphorylation | Bone marrow | Homeostasis | Iron | Grants | Metabolism | Gene expression | Experiments | Hemorrhage
OVERLOAD | HOMEOSTASIS | DIFFERENTIATION FACTOR 15 | BETA-THALASSEMIA-INTERMEDIA | ERYTHROPOIESIS | GENETICS & HEREDITY | MOUSE-LIVER | MICE | HEPCIDIN EXPRESSION | ANEMIA | HYPOXIA | Hepcidins - metabolism | beta-Thalassemia - pathology | Liver - pathology | Iron Overload - drug therapy | Molecular Sequence Data | Erythropoiesis - drug effects | Male | Gene Expression Profiling | Iron Overload - pathology | Iron Overload - metabolism | Epoetin Alfa | Erythropoietin - metabolism | Real-Time Polymerase Chain Reaction | Anemia - etiology | Disease Models, Animal | Recombinant Proteins - metabolism | Hormones - pharmacology | Enzyme-Linked Immunosorbent Assay | Liver - metabolism | Mice, Inbred C57BL | RNA, Messenger - genetics | Hemorrhage - complications | Hemoglobins - metabolism | Hemorrhage - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Iron - metabolism | Blotting, Western | Erythropoiesis - physiology | Mice, Knockout | Anemia - metabolism | Animals | Mice | beta-Thalassemia - metabolism | Physiological aspects | Genetic research | Genetic aspects | Iron in the body | Hormones | Research | Genetic regulation | Identification and classification | Flow cytometry | Plasma | Phosphorylation | Bone marrow | Homeostasis | Iron | Grants | Metabolism | Gene expression | Experiments | Hemorrhage
Journal Article
Haematologica, ISSN 0390-6078, 11/2017, Volume 102, Issue 12, pp. 1972 - 1984
Ferroportin Disease (FD) is an autosomal dominant hereditary iron loading disorder associated with heterozygote mutations of the ferroportin-1 (FPN) gene. It...
MOLECULAR-MECHANISM | PRIMARY IRON OVERLOAD | AFRICAN-AMERICAN MAN | SLC40A1 GENE | JUVENILE HEMOCHROMATOSIS | MISSENSE MUTATION | FUNCTIONAL-ANALYSIS | AUTOSOMAL-DOMINANT HEMOCHROMATOSIS | HEREDITARY HEMOCHROMATOSIS | HEMATOLOGY | RESPONSIVE ELEMENT | Kupffer Cells - pathology | Iron Overload - genetics | Humans | Iron Overload - therapy | Phlebotomy | Cation Transport Proteins - genetics | Mutation | Iron Overload - pathology | Iron Overload - diagnosis | Review
MOLECULAR-MECHANISM | PRIMARY IRON OVERLOAD | AFRICAN-AMERICAN MAN | SLC40A1 GENE | JUVENILE HEMOCHROMATOSIS | MISSENSE MUTATION | FUNCTIONAL-ANALYSIS | AUTOSOMAL-DOMINANT HEMOCHROMATOSIS | HEREDITARY HEMOCHROMATOSIS | HEMATOLOGY | RESPONSIVE ELEMENT | Kupffer Cells - pathology | Iron Overload - genetics | Humans | Iron Overload - therapy | Phlebotomy | Cation Transport Proteins - genetics | Mutation | Iron Overload - pathology | Iron Overload - diagnosis | Review
Journal Article
Blood, ISSN 0006-4971, 07/2017, Volume 130, Issue 3, pp. 245 - 257
The iron-regulatory hormone hepcidin is induced early in infection, causing iron sequestration in macrophages and decreased plasma iron; this is proposed to...
OVERLOAD | MENINGITIS | VIBRIO-VULNIFICUS | DEFEROXAMINE | YERSINIA-ENTEROCOLITICA | TUBERCULOSIS | SUSCEPTIBILITY | STAPHYLOCOCCUS-AUREUS | VIRULENCE | HEMATOLOGY | HEMOCHROMATOSIS | Iron Overload - mortality | Catheter-Related Infections - metabolism | Yersinia enterocolitica - drug effects | Humans | Iron Overload - immunology | Hemochromatosis - metabolism | Mycobacterium tuberculosis - drug effects | Transferrin - genetics | Iron Overload - microbiology | Hemochromatosis - microbiology | Iron Overload - metabolism | Hepcidins - immunology | Catheter-Related Infections - mortality | Hepcidins - agonists | Staphylococcal Infections - microbiology | Mycobacterium tuberculosis - metabolism | Staphylococcus aureus | Disease Models, Animal | Staphylococcal Infections - metabolism | Binding, Competitive | Gene Expression | Disease Resistance | Staphylococcal Infections - immunology | Mice, Inbred C57BL | Iron - immunology | Iron - metabolism | Mice, Knockout | Staphylococcal Infections - mortality | Animals | Catheter-Related Infections - microbiology | Survival Analysis | Yersinia enterocolitica - metabolism | Catheter-Related Infections - immunology | Hemochromatosis - immunology | Hepcidins - genetics | Protein Binding | Yersinia enterocolitica - growth & development | Hemochromatosis - mortality | Hepcidins - deficiency | Mice | Oligopeptides - pharmacology | Transferrin - metabolism | Mycobacterium tuberculosis - growth & development | Plenary Paper
OVERLOAD | MENINGITIS | VIBRIO-VULNIFICUS | DEFEROXAMINE | YERSINIA-ENTEROCOLITICA | TUBERCULOSIS | SUSCEPTIBILITY | STAPHYLOCOCCUS-AUREUS | VIRULENCE | HEMATOLOGY | HEMOCHROMATOSIS | Iron Overload - mortality | Catheter-Related Infections - metabolism | Yersinia enterocolitica - drug effects | Humans | Iron Overload - immunology | Hemochromatosis - metabolism | Mycobacterium tuberculosis - drug effects | Transferrin - genetics | Iron Overload - microbiology | Hemochromatosis - microbiology | Iron Overload - metabolism | Hepcidins - immunology | Catheter-Related Infections - mortality | Hepcidins - agonists | Staphylococcal Infections - microbiology | Mycobacterium tuberculosis - metabolism | Staphylococcus aureus | Disease Models, Animal | Staphylococcal Infections - metabolism | Binding, Competitive | Gene Expression | Disease Resistance | Staphylococcal Infections - immunology | Mice, Inbred C57BL | Iron - immunology | Iron - metabolism | Mice, Knockout | Staphylococcal Infections - mortality | Animals | Catheter-Related Infections - microbiology | Survival Analysis | Yersinia enterocolitica - metabolism | Catheter-Related Infections - immunology | Hemochromatosis - immunology | Hepcidins - genetics | Protein Binding | Yersinia enterocolitica - growth & development | Hemochromatosis - mortality | Hepcidins - deficiency | Mice | Oligopeptides - pharmacology | Transferrin - metabolism | Mycobacterium tuberculosis - growth & development | Plenary Paper
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2013, Volume 60, Issue 2, pp. 354 - 361
Background & Aims The liver, being the major site of iron storage, is particularly exposed to the toxic effects of iron. Transcription factor NRF2 is critical...
Gastroenterology and Hepatology | Mito-TEMPOL | Hemochromatosis | 8-Hydroxy-2′-deoxyguanosine | Hepatocyte | Antioxidant | Necrosis | 8-Hydroxy-2′- deoxyguanosine | OVERLOAD | APOPTOSIS | OXIDATIVE STRESS | FERRIC NITRILOTRIACETATE | 8-Hydroxy-2'-deoxyguanosine | PLASMA | METABOLISM | PATHWAY | ONCOTIC NECROSIS | MITOCHONDRIAL DYSFUNCTION | GASTROENTEROLOGY & HEPATOLOGY | Liver - pathology | Iron Overload - drug therapy | Mitochondria, Liver - metabolism | Liver - metabolism | Mice, Inbred C57BL | Hepatocytes - pathology | Male | Antioxidants - pharmacology | Hepatocytes - metabolism | Spin Labels | Iron Overload - pathology | NF-E2-Related Factor 2 - deficiency | Iron, Dietary - toxicity | Mice, Knockout | Liver - injuries | Mitochondria, Liver - drug effects | Animals | Iron Overload - metabolism | Cyclic N-Oxides - pharmacology | NF-E2-Related Factor 2 - metabolism | NF-E2-Related Factor 2 - genetics | Mice | Hepatocytes - drug effects | Disease Models, Animal | Prevention | Iron | Liver diseases | Cell death | Liver | Index Medicus
Gastroenterology and Hepatology | Mito-TEMPOL | Hemochromatosis | 8-Hydroxy-2′-deoxyguanosine | Hepatocyte | Antioxidant | Necrosis | 8-Hydroxy-2′- deoxyguanosine | OVERLOAD | APOPTOSIS | OXIDATIVE STRESS | FERRIC NITRILOTRIACETATE | 8-Hydroxy-2'-deoxyguanosine | PLASMA | METABOLISM | PATHWAY | ONCOTIC NECROSIS | MITOCHONDRIAL DYSFUNCTION | GASTROENTEROLOGY & HEPATOLOGY | Liver - pathology | Iron Overload - drug therapy | Mitochondria, Liver - metabolism | Liver - metabolism | Mice, Inbred C57BL | Hepatocytes - pathology | Male | Antioxidants - pharmacology | Hepatocytes - metabolism | Spin Labels | Iron Overload - pathology | NF-E2-Related Factor 2 - deficiency | Iron, Dietary - toxicity | Mice, Knockout | Liver - injuries | Mitochondria, Liver - drug effects | Animals | Iron Overload - metabolism | Cyclic N-Oxides - pharmacology | NF-E2-Related Factor 2 - metabolism | NF-E2-Related Factor 2 - genetics | Mice | Hepatocytes - drug effects | Disease Models, Animal | Prevention | Iron | Liver diseases | Cell death | Liver | Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2010, Volume 56, Issue 13, pp. 1001 - 1012
The prevalence of iron overload cardiomyopathy (IOC) is increasing. The spectrum of symptoms of IOC is varied. Early in the disease process, patients may be...
iron overload cardiomyopathy | calcium channel blockers | T2 MRI | chelation | hemochromatosis | hemosiderosis | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIAC IRON | BONE-MARROW-TRANSPLANTATION | MYOCARDIAL IRON | HEREDITARY HEMOCHROMATOSIS | SERUM FERRITIN | T2MRI | BETA-THALASSEMIA MAJOR | T2-ASTERISK-CARDIOVASCULAR MAGNETIC-RESONANCE | SICKLE-CELL-DISEASE | IDIOPATHIC HEMOCHROMATOSIS | ENDOMYOCARDIAL BIOPSY | Cardiomyopathies - blood | Echocardiography | Humans | Myocardium - pathology | Tomography, X-Ray Computed | Biomarkers - blood | Cardiomyopathies - etiology | Critical Pathways | Cardiomyopathies - therapy | Iron Overload - blood | Magnetic Resonance Imaging | Iron Overload - complications | Iron - physiology | Biopsy | Iron Overload - therapy | Cardiomyopathies - diagnosis | Iron Overload - diagnosis | Heart failure | Free radicals | Liver diseases | Transplants & implants | Ischemia | Cardiomyopathy | Rodents | Mortality | Homeostasis | Mutation | Sickle cell disease | Blood | Iron overload cardiomyopathy
iron overload cardiomyopathy | calcium channel blockers | T2 MRI | chelation | hemochromatosis | hemosiderosis | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIAC IRON | BONE-MARROW-TRANSPLANTATION | MYOCARDIAL IRON | HEREDITARY HEMOCHROMATOSIS | SERUM FERRITIN | T2MRI | BETA-THALASSEMIA MAJOR | T2-ASTERISK-CARDIOVASCULAR MAGNETIC-RESONANCE | SICKLE-CELL-DISEASE | IDIOPATHIC HEMOCHROMATOSIS | ENDOMYOCARDIAL BIOPSY | Cardiomyopathies - blood | Echocardiography | Humans | Myocardium - pathology | Tomography, X-Ray Computed | Biomarkers - blood | Cardiomyopathies - etiology | Critical Pathways | Cardiomyopathies - therapy | Iron Overload - blood | Magnetic Resonance Imaging | Iron Overload - complications | Iron - physiology | Biopsy | Iron Overload - therapy | Cardiomyopathies - diagnosis | Iron Overload - diagnosis | Heart failure | Free radicals | Liver diseases | Transplants & implants | Ischemia | Cardiomyopathy | Rodents | Mortality | Homeostasis | Mutation | Sickle cell disease | Blood | Iron overload cardiomyopathy
Journal Article
Communication et organisation, ISSN 1168-5549, 01/2012, Volume 41, pp. 181 - 194
// ABSTRACT IN ENGLISH: This article attempts to capture and characterize the competency model of framing communication in universities. This model is...
Overload
Overload
Journal Article
Gastroenterology, ISSN 0016-5085, 2008, Volume 134, Issue 1, pp. 102 - 110
Background & Aims: The influence of HFE gene mutations and liver iron overload on hepatocellular carcinoma (HCC) occurrence in patients with cirrhosis is...
Gastroenterology and Hepatology | SURVIVAL | OVERLOAD | DISEASES | CHRONIC HEPATITIS-C | ALCOHOLIC CIRRHOSIS | HEMOCHROMATOSIS GENE | DEATH | ACCUMULATION | PREVALENCE | GASTROENTEROLOGY & HEPATOLOGY | Hepatitis C - metabolism | Hemochromatosis Protein | Humans | Middle Aged | Male | Liver Neoplasms - etiology | Iron Overload - metabolism | Adult | Female | Hepatitis C - complications | Carcinoma, Hepatocellular - etiology | Liver Cirrhosis, Alcoholic - complications | Iron Overload - genetics | Membrane Proteins - genetics | Liver - metabolism | Hepatitis C - genetics | Histocompatibility Antigens Class I - genetics | Mutation - genetics | Iron Overload - complications | Liver Cirrhosis, Alcoholic - genetics | Liver Neoplasms - metabolism | Aged | Liver Cirrhosis, Alcoholic - metabolism | Carcinoma, Hepatocellular - metabolism | Cohort Studies | Care and treatment | Gene mutations | Analysis | Liver | Genetic aspects | Iron | Hepatoma | Liver cirrhosis | Risk factors | Cancer | Histocompatibility Antigens Class I | Liver Neoplasms | Liver Cirrhosis, Alcoholic | Membrane Proteins | Life Sciences | Santé publique et épidémiologie | Mutation | Carcinoma, Hepatocellular | Hepatitis C | Iron Overload
Gastroenterology and Hepatology | SURVIVAL | OVERLOAD | DISEASES | CHRONIC HEPATITIS-C | ALCOHOLIC CIRRHOSIS | HEMOCHROMATOSIS GENE | DEATH | ACCUMULATION | PREVALENCE | GASTROENTEROLOGY & HEPATOLOGY | Hepatitis C - metabolism | Hemochromatosis Protein | Humans | Middle Aged | Male | Liver Neoplasms - etiology | Iron Overload - metabolism | Adult | Female | Hepatitis C - complications | Carcinoma, Hepatocellular - etiology | Liver Cirrhosis, Alcoholic - complications | Iron Overload - genetics | Membrane Proteins - genetics | Liver - metabolism | Hepatitis C - genetics | Histocompatibility Antigens Class I - genetics | Mutation - genetics | Iron Overload - complications | Liver Cirrhosis, Alcoholic - genetics | Liver Neoplasms - metabolism | Aged | Liver Cirrhosis, Alcoholic - metabolism | Carcinoma, Hepatocellular - metabolism | Cohort Studies | Care and treatment | Gene mutations | Analysis | Liver | Genetic aspects | Iron | Hepatoma | Liver cirrhosis | Risk factors | Cancer | Histocompatibility Antigens Class I | Liver Neoplasms | Liver Cirrhosis, Alcoholic | Membrane Proteins | Life Sciences | Santé publique et épidémiologie | Mutation | Carcinoma, Hepatocellular | Hepatitis C | Iron Overload
Journal Article
Transfusion, ISSN 0041-1132, 03/2017, Volume 57, Issue 3, pp. 700 - 704
BACKGROUND Use of chronic blood transfusions as a treatment modality in patients with blood disorders places them at risk for iron overload. Since patients...
OVERLOAD | MORTALITY | MORBIDITY | TRANSFUSED PATIENTS | MAGNETIC-RESONANCE | BETA-THALASSEMIA | HEMATOLOGY | Anemia, Sickle Cell - physiopathology | Arrhythmias, Cardiac - therapy | Anemia, Sickle Cell - complications | Humans | Male | Arrhythmias, Cardiac - etiology | Iron Overload - physiopathology | Arrhythmias, Cardiac - physiopathology | Iron Overload - blood | Iron Overload - etiology | Anemia, Sickle Cell - therapy | Ferritins - blood | Iron Overload - therapy | Adult | Female | Arrhythmias, Cardiac - blood | Anemia, Sickle Cell - blood | Iron - blood | Heart | Sickle cell anemia | Mortality | Cardiac patients | Ferritin | Disease susceptibility | Diagnostic imaging | Blood transfusion | Index Medicus | cardiac iron overload | iron chelation | blood transfusion | sickle cell disease
OVERLOAD | MORTALITY | MORBIDITY | TRANSFUSED PATIENTS | MAGNETIC-RESONANCE | BETA-THALASSEMIA | HEMATOLOGY | Anemia, Sickle Cell - physiopathology | Arrhythmias, Cardiac - therapy | Anemia, Sickle Cell - complications | Humans | Male | Arrhythmias, Cardiac - etiology | Iron Overload - physiopathology | Arrhythmias, Cardiac - physiopathology | Iron Overload - blood | Iron Overload - etiology | Anemia, Sickle Cell - therapy | Ferritins - blood | Iron Overload - therapy | Adult | Female | Arrhythmias, Cardiac - blood | Anemia, Sickle Cell - blood | Iron - blood | Heart | Sickle cell anemia | Mortality | Cardiac patients | Ferritin | Disease susceptibility | Diagnostic imaging | Blood transfusion | Index Medicus | cardiac iron overload | iron chelation | blood transfusion | sickle cell disease
Journal Article
Journal of Cardiovascular Magnetic Resonance, ISSN 1097-6647, 2008, Volume 10, Issue 1, pp. 42 - 42
Background: The UK Thalassaemia Register records births, deaths and selected clinical data of patients with thalassaemia who are resident in the UK. A study of...
CARDIAC & CARDIOVASCULAR SYSTEMS | DEFEROXAMINE | TRANSFUSIONAL IRON OVERLOAD | TRANSFERABILITY | CARDIOMYOPATHY | MYOCARDIAL IRON | DESFERRIOXAMINE | BETA-THALASSEMIA | DEFERIPRONE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | COMBINED THERAPY | CHELATION | beta-Thalassemia - pathology | Anemia - mortality | Iron Overload - mortality | Humans | Middle Aged | Child, Preschool | Male | beta-Thalassemia - complications | Iron Overload - pathology | beta-Thalassemia - mortality | Cardiomyopathies - etiology | Cause of Death | Iron Overload - etiology | Young Adult | Time Factors | Cardiomyopathies - mortality | Life Expectancy | Adult | Female | Registries | Child | Anemia - etiology | Communicable Diseases - mortality | Iron Chelating Agents - therapeutic use | beta-Thalassemia - therapy | Cardiomyopathies - pathology | Treatment Outcome | United Kingdom | Cardiomyopathies - therapy | Magnetic Resonance Imaging | Bone Marrow Transplantation - mortality | Iron Overload - therapy | Adolescent | Bone Marrow Transplantation - adverse effects | Pyridones - therapeutic use | Communicable Diseases - complications | Usage | Control | Magnetic resonance imaging | Patient outcomes | Physiological aspects | Thalassemia | Iron in the body | Heart diseases | Risk factors
CARDIAC & CARDIOVASCULAR SYSTEMS | DEFEROXAMINE | TRANSFUSIONAL IRON OVERLOAD | TRANSFERABILITY | CARDIOMYOPATHY | MYOCARDIAL IRON | DESFERRIOXAMINE | BETA-THALASSEMIA | DEFERIPRONE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | COMBINED THERAPY | CHELATION | beta-Thalassemia - pathology | Anemia - mortality | Iron Overload - mortality | Humans | Middle Aged | Child, Preschool | Male | beta-Thalassemia - complications | Iron Overload - pathology | beta-Thalassemia - mortality | Cardiomyopathies - etiology | Cause of Death | Iron Overload - etiology | Young Adult | Time Factors | Cardiomyopathies - mortality | Life Expectancy | Adult | Female | Registries | Child | Anemia - etiology | Communicable Diseases - mortality | Iron Chelating Agents - therapeutic use | beta-Thalassemia - therapy | Cardiomyopathies - pathology | Treatment Outcome | United Kingdom | Cardiomyopathies - therapy | Magnetic Resonance Imaging | Bone Marrow Transplantation - mortality | Iron Overload - therapy | Adolescent | Bone Marrow Transplantation - adverse effects | Pyridones - therapeutic use | Communicable Diseases - complications | Usage | Control | Magnetic resonance imaging | Patient outcomes | Physiological aspects | Thalassemia | Iron in the body | Heart diseases | Risk factors
Journal Article